Kansas City Cancer Center

Kansas City, Missouri 66210

0 studies enrolling now · 13 studies all time

What they study most

Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, ER+ Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Graft-versus-Host Disease, Lymphoma, Non-Hodgkin, Mantle Cell Lymphoma, Melanoma, Multiple Myeloma, Nausea and Vomiting

Studies at this site

• Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer — Stopped early
• Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer — Completed
• Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease — Completed
• Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease — Completed
• Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) — Completed
• Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients — Completed
• Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients — Completed
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer — Completed
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen — Status unconfirmed